DK3377064T3 - Orvepitant til behandling af kronisk hoste - Google Patents

Orvepitant til behandling af kronisk hoste Download PDF

Info

Publication number
DK3377064T3
DK3377064T3 DK16819325.8T DK16819325T DK3377064T3 DK 3377064 T3 DK3377064 T3 DK 3377064T3 DK 16819325 T DK16819325 T DK 16819325T DK 3377064 T3 DK3377064 T3 DK 3377064T3
Authority
DK
Denmark
Prior art keywords
orvepantant
treatment
chronic cough
cough
chronic
Prior art date
Application number
DK16819325.8T
Other languages
English (en)
Inventor
Mike Trower
Original Assignee
Nerre Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nerre Therapeutics Ltd filed Critical Nerre Therapeutics Ltd
Application granted granted Critical
Publication of DK3377064T3 publication Critical patent/DK3377064T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
DK16819325.8T 2016-01-08 2016-12-27 Orvepitant til behandling af kronisk hoste DK3377064T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662276237P 2016-01-08 2016-01-08
US201662408921P 2016-10-17 2016-10-17
PCT/EP2016/082698 WO2017118584A1 (en) 2016-01-08 2016-12-27 Orvepitant for the treatment of chronic cough

Publications (1)

Publication Number Publication Date
DK3377064T3 true DK3377064T3 (da) 2019-09-23

Family

ID=57629591

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16819325.8T DK3377064T3 (da) 2016-01-08 2016-12-27 Orvepitant til behandling af kronisk hoste

Country Status (21)

Country Link
US (2) US9750739B2 (da)
EP (1) EP3377064B1 (da)
JP (1) JP6621534B2 (da)
KR (1) KR102136017B1 (da)
CN (2) CN108430475B (da)
AU (1) AU2016384267B2 (da)
BR (1) BR112018013903B1 (da)
CA (1) CA3009283C (da)
CY (1) CY1122170T1 (da)
DK (1) DK3377064T3 (da)
ES (1) ES2738678T3 (da)
HR (1) HRP20191725T1 (da)
HU (1) HUE045764T2 (da)
LT (1) LT3377064T (da)
MX (1) MX371178B (da)
PL (1) PL3377064T3 (da)
PT (1) PT3377064T (da)
RS (1) RS59313B1 (da)
RU (1) RU2746601C2 (da)
SI (1) SI3377064T1 (da)
WO (1) WO2017118584A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018136554A1 (en) * 2017-01-17 2018-07-26 Menlo Therapeutics Inc. Use of neurokinin-1 antagonists as antitussives
SG11202100580UA (en) * 2018-07-23 2021-02-25 Trevi Therapeutics Inc Treatment of chronic cough, breathlessness and dyspnea
CN112823795B (zh) * 2019-11-20 2023-04-14 天津医科大学总医院 一种特发性肺纤维化药物组合及其应用
MX2022011545A (es) * 2020-04-03 2022-11-09 Nerre Therapeutics Ltd Un antagonista de receptor de nk-1 para tratar una enfermedad que se selecciona de sepsis, choque septico, síndrome de dificultad respiratoria aguda (ards) 0 síndrome de disfunción orgánica múltiple (mcds).
IL298589A (en) * 2020-06-02 2023-01-01 Nerre Therapeutics Ltd Neurokinin (nk)-1 receptor antagonists for use in the treatment of pulmonary fibrosis promoted by mechanical lung injury
CN114732818B (zh) * 2022-04-29 2023-02-10 首都医科大学附属北京胸科医院 一种抗特发性肺纤维化药物尼达尼布在结核病治疗中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ321575A (en) * 1995-10-30 1999-05-28 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4- substituted piperazine derivatives
GB0203020D0 (en) * 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
GB0806652D0 (en) * 2008-04-11 2008-05-14 Glaxo Group Ltd Anhydrous crystal form of orvepitant maleate
CA2884454C (en) * 2012-10-11 2021-07-27 Nerre Therapeutics Limited Orvepitant and uses thereof

Also Published As

Publication number Publication date
EP3377064A1 (en) 2018-09-26
RU2018122121A3 (da) 2020-06-26
HUE045764T2 (hu) 2020-01-28
US20170326140A1 (en) 2017-11-16
KR20180100651A (ko) 2018-09-11
ES2738678T3 (es) 2020-01-24
AU2016384267A1 (en) 2018-07-05
PT3377064T (pt) 2019-07-23
RU2018122121A (ru) 2020-02-11
WO2017118584A1 (en) 2017-07-13
PL3377064T3 (pl) 2020-02-28
BR112018013903A2 (pt) 2018-12-18
KR102136017B1 (ko) 2020-07-20
LT3377064T (lt) 2019-09-10
CA3009283A1 (en) 2017-07-13
BR112018013903B1 (pt) 2023-11-07
US9750739B2 (en) 2017-09-05
US20170196860A1 (en) 2017-07-13
EP3377064B1 (en) 2019-06-26
CN108430475A (zh) 2018-08-21
CN108430475B (zh) 2021-03-16
MX2018008439A (es) 2018-08-14
JP2019501162A (ja) 2019-01-17
AU2016384267B2 (en) 2022-02-03
RU2746601C2 (ru) 2021-04-16
HRP20191725T1 (hr) 2019-12-27
RS59313B1 (sr) 2019-10-31
CN113274392A (zh) 2021-08-20
SI3377064T1 (sl) 2019-11-29
CY1122170T1 (el) 2020-11-25
MX371178B (es) 2020-01-21
JP6621534B2 (ja) 2019-12-18
CA3009283C (en) 2023-10-03

Similar Documents

Publication Publication Date Title
DK3512850T3 (da) Inhibitorer af menin-mll-interaktionen
DK3468966T3 (da) Inhibitorer af menin-mll-interaktionen
DK3405050T3 (da) Børnesikret snusbeholder
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3556775T3 (da) Anti-lag-3 antistoffer til behandling af hæmatologiske maligniteter
DK3466432T3 (da) Fremgangsmåder til behandling af pulmonale non-tuberkuløse mykobakterielle infektioner
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3436823T3 (da) Antigen-array
DK3134084T3 (da) Fremgangsmåde til behandling af lungeadenokarcinom
DK3524255T3 (da) Sammensætning til behandling af acne
DK3445708T3 (da) Stigbøjle
DK3377064T3 (da) Orvepitant til behandling af kronisk hoste
DK3402792T3 (da) Quinolin-2-on-derivater
DK3335532T3 (da) Tandharve
DK3509963T3 (da) Pallecontainer
DK3076224T3 (da) Feltkartograf
DK3528829T3 (da) Bacitracin-alginat-oligomer-konjugater
DK3575238T3 (da) Pallecontainer
DE112017006386A5 (de) Schraubarbeitszylinder
DE112017000734A5 (de) Glycolsensor
DK3471535T3 (da) Dyrelift
DK3586840T3 (da) Mmp7-hæmmere til anvendelse i behandling af cystitis
DK3323708T3 (da) Bovfender
DK3452590T3 (da) Plademagnet
DK3295800T3 (da) Sandwichkiksindretning